SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-19-162638
Filing Date
2019-05-31
Accepted
2019-05-31 14:37:32
Documents
1
Effectiveness Date
2019-05-31

Document Format Files

Seq Description Document Type Size
1 15-12B d742028d1512b.htm 15-12B 11447
  Complete submission text file 0001193125-19-162638.txt   12478
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-33415 | Film No.: 19869948
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences